27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

12 th <strong>Congress</strong> <strong>of</strong> <strong>the</strong> <strong>European</strong> <strong>Hematology</strong> Association<br />

status, monoclonal immunoglobulins (MG) and plasmacytic differentiation<br />

(PD). All patients with follow-up at our institution were analysed,<br />

and influence <strong>of</strong> various parameters on dissemination and outcome were<br />

evaluated. Sixty-five patients (38%) had gastric MALT-lymphoma (GML)<br />

and 108 (62%) extragastric MALT-lymphoma (EGML). Results. 68/172<br />

patients (39%) had multiorgan-involvement upon presentation, while<br />

only 3 patients had bone marrow involvement. Patients with EGML<br />

(51/108, 47%) were at significantly higher risk for multiorgan-disease<br />

than patients with GML (17/65, 27%, p=0.013). 58 patients had genetic<br />

aberrations, with t(11;18) being more common in GML (p=0.002) and trisomy<br />

3 (p=0.03) and trisomy 18 (p=0.02) in EGML. Among GML, translocation<br />

t(11;18) was significantly associated with multiorgan-disease, as<br />

was trisomy18 in EGML (p=0.038). After a median follow-up time <strong>of</strong> 42<br />

months, 142 patients (86%) are alive.58 patients (39%) have relapsed,<br />

with <strong>the</strong> median to relapse being 60 months. Overall, multifocality and<br />

extragastric origin (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!